Therapeutic cytapheresis in chronic lymphocytic leukemia | Zendy

Marti G. E. | Zendy; Folks T. | Zendy; Longo D. L. | Zendy; Klein H. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Therapeutic cytapheresis in chronic lymphocytic leukemia

Author(s) -

Marti G. E.,

Folks T.,

Longo D. L.,

Klein H.

Publication year - 1983

Publication title -

journal of clinical apheresis

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.697

H-Index - 46

eISSN - 1098-1101

pISSN - 0733-2459

DOI - 10.1002/jca.2920010408

Subject(s) - medicine , hepatosplenomegaly , chronic lymphocytic leukemia , lymphocytosis , apheresis , anemia , leukemia , autoimmune hemolytic anemia , immunology , gastroenterology , platelet , disease

The role of therapeutic reductive lymphapheresis in 59 patients with chronic lymphocytic leukemia (CLL) was reviewed. Reduction in lymphocytosis, lymphadenopathy and hepatosplenomegaly was noted in 50%–60% of the patients studied. In addition to mobilization of the lymphoid tumor load, 40% of the patients showed an improvement in their hemogram. Although apheresis‐induced anemia can occur, reported complications were minimal. These studies suggest that a majority of CLL patients might benefit from therapeutic lymphapheresis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research